CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE Drug Patent Profile
✉ Email this page to a colleague
When do Calcipotriene And Betamethasone Dipropionate patents expire, and what generic alternatives are available?
Calcipotriene And Betamethasone Dipropionate is a drug marketed by Glenmark Pharms Ltd, Chartwell Rx, Padagis Israel, Cosette, and Taro. and is included in five NDAs.
The generic ingredient in CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE is betamethasone dipropionate; calcipotriene. There are sixty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE?
- What are the global sales for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE?
- What is Average Wholesale Price for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE?
Summary for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 3 |
| Clinical Trials: | 16 |
| Patent Applications: | 66 |
| What excipients (inactive ingredients) are in CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE? | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE excipients list |
| DailyMed Link: | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE at DailyMed |
Recent Clinical Trials for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Alabama at Birmingham | Phase 4 |
| Eli Lilly and Company | Phase 4 |
| Celgene Corporation | Phase 4 |
See all CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE clinical trials
Pharmacology for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
| Drug Class | Corticosteroid Vitamin D Analog |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Pharms Ltd | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | betamethasone dipropionate; calcipotriene | AEROSOL, FOAM;TOPICAL | 214688-001 | Mar 21, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Cosette | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | betamethasone dipropionate; calcipotriene | SUSPENSION;TOPICAL | 210765-001 | May 11, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Rx | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | betamethasone dipropionate; calcipotriene | OINTMENT;TOPICAL | 201615-001 | Jan 14, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
